Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL251768 | 0.98 | CYP1A2 (0.64) | CYP1A2CYP2D6NPSR1 | |
| SCHEMBL28278980 | 0.86 | CYP1A2 (0.85) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL28388391 | 0.85 | CYP1A2 (0.64) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL6017813 | 0.84 | CYP1A2 (0.52) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL22720087 | 0.84 | CYP1A2 (0.81) | CYP1A2CYP2D6 | |
| SCHEMBL5494207 | 0.83 | CYP1A2 (0.47) | CYP1A2CYP2D6NPSR1 | |
| SCHEMBL9744796 | 0.83 | CYP1A2 (0.62) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL19582944 | 0.82 | CYP1A2 (0.60) | CYP1A2CYP2D6 | |
| Succinimide SCHEMBL14977585 | 0.81 | CYP1A2 (0.46) | CYP1A2CYP2D6NPSR1 | |
| SCHEMBL18791748 | 0.81 | CYP1A2 (0.70) | CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146245-A1 | COMPOSITION FOR DIAGNOSING TUBERCULOSIS BY USING BIOMARKER, AND TUBERCULOSIS DIAGNOSTIC METHOD AND KIT USING SAME | 주식회사 더다봄 | 2023-08-03 | — | — | WO | claimed |
| US-11560635-B2 | Electrode for gas generation, method of preparing the electrode and device including the electrode for gas generation | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2023-01-24 | — | — | US | claimed |
| WO-2021122356-A1 | PROCESS FOR PREPARING FLURALANER | KRKA, D.D., NOVO MESTO (SI) | 2021-06-24 | — | — | WO | claimed |
| US-20200325586-A1 | Electrode for Gas Generation, Method of Preparing the Electrode and Device Including the Electrode for Gas Generation | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2020-10-15 | — | — | US | claimed |
| EP-1915449-B1 | SIRNA-HYDROPHILIC POLYMER CONJUGATES FOR INTRACELLULAR DELIVERY OF SIRNA AND METHOD THEREOF | BIONEER CORP (KR) | 2016-03-23 | — | — | EP | claimed |
| US-8835632-B2 | Methods to increase the photostability of dyes | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2014-09-16 | — | — | US | claimed |
| US-7917298-B1 | Nanocrystal taggants | NANOSYS, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20110046000-A1 | METHODS TO INCREASE THE PHOTOSTABILITY OF DYES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-02-24 | — | — | US | claimed |
| US-20100028402-A1 | NANOPARTICLE-BASED ANTICOAGULANT | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2010-02-04 | — | — | US | claimed |
| US-7592188-B2 | environmentally sensitive fluorescent dye covalently linked to a binding domain which has specific affinity for a target molecule; fluorescence resonance energy transfer; detecting changes in the binding, conformational change; detecting human immunodeficiency virus | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-09-22 | — | — | US | claimed |
| WO-2005088308-A2 | FLUORESCENT SIGNAL EMITTING LIVE CELL BIOSENSOR MOLECULES AND DYES FOR DETECTION AND QUANTIFICATION OF PROTEIN ACTIVITIES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-09-22 | — | — | WO | claimed |
| US-20050087719-A1 | Stabilizers; high saturation polarization and biocompatibility | BERLIN HEART AG (DE) | 2005-04-28 | — | — | US | claimed |
| EP-1213587-A1 | Particles having gelatin coatings of and processes for making same | Coulter International Corporation (US) | 2002-06-12 | — | — | EP | claimed |
| EP-0665955-B1 | PARTICLES HAVING GELATIN-AMINODEXTRAN COATINGS OF AND PROCESSES FOR MAKING SAME | COULTER INT CORP (US) | 2002-05-29 | — | — | EP | claimed |
| US-5487895-A | Method for forming controlled release polymeric substrate | VITAPHORE CORPORATION (US) | 1996-01-30 | — | — | US | claimed |
| EP-0664698-A1 | METHOD FOR FORMING CONTROLLED RELEASE POLYMERIC SUBSTRATE | VITAPHORE CORPORATION (US) | 1995-08-02 | — | — | EP | claimed |
| WO-1995005162-A1 | METHOD FOR FORMING CONTROLLED RELEASE POLYMERIC SUBSTRATE | VITAPHORE CORPORATION (US) | 1995-02-23 | — | — | WO | claimed |
| EP-0220657-B1 | CONJUGATE OF 9-(2-HYDROXYETHOXYMETHYL)-GUANINE WITH LACTOSAMINATED HUMAN ALBUMIN, PROCESS FOR THE PEPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | LABORATORI BALDACCI Spa (IT) | 1991-08-14 | — | — | EP | claimed |
| US-4725672-A | HEPATITIS | LABORATORI BALDACCI S.P.A. (IT) | 1988-02-16 | — | — | US | claimed |
| EP-0220657-A2 | Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin, process for the peparation thereof and pharmaceutical compositions containing it | LABORATORI BALDACCI Spa (IT) | 1987-05-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046000-A1 | METHODS TO INCREASE THE PHOTOSTABILITY OF DYES | PTMS, ACP1, SNRPE | CYP1A2 4855/4885CYP2D6 4716/4885NPSR1 3498/4885 |
| US-20100028402-A1 | NANOPARTICLE-BASED ANTICOAGULANT | SERPINC1, F2, ADAMTS13 | CYP1A2 1340/4885CYP2D6 2483/4885NPSR1 1590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.